UTI Statistics
Total Valuation
UTI has a market cap or net worth of $1.60 billion. The enterprise value is $1.78 billion.
| Market Cap | 1.60B |
| Enterprise Value | 1.78B |
Important Dates
The last earnings date was Wednesday, August 5, 2026, after market close.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
UTI has 55.10 million shares outstanding. The number of shares has increased by 0.30% in one year.
| Current Share Class | 55.10M |
| Shares Outstanding | 55.10M |
| Shares Change (YoY) | +0.30% |
| Shares Change (QoQ) | +0.37% |
| Owned by Insiders (%) | 2.43% |
| Owned by Institutions (%) | 104.55% |
| Float | 53.17M |
Valuation Ratios
The trailing PE ratio is 47.46 and the forward PE ratio is 35.54. UTI's PEG ratio is 2.37.
| PE Ratio | 47.46 |
| Forward PE | 35.54 |
| PS Ratio | 1.81 |
| Forward PS | 1.66 |
| PB Ratio | 4.63 |
| P/TBV Ratio | 5.49 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 21.41 |
| PEG Ratio | 2.37 |
Enterprise Valuation
| EV / Earnings | 52.03 |
| EV / Sales | 2.02 |
| EV / EBITDA | 16.66 |
| EV / EBIT | 40.32 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.30, with a Debt / Equity ratio of 1.04.
| Current Ratio | 1.30 |
| Quick Ratio | 1.11 |
| Debt / Equity | 1.04 |
| Debt / EBITDA | 3.36 |
| Debt / FCF | n/a |
| Interest Coverage | 11.39 |
Financial Efficiency
Return on equity (ROE) is 10.53% and return on invested capital (ROIC) is 6.54%.
| Return on Equity (ROE) | 10.53% |
| Return on Assets (ROA) | 3.38% |
| Return on Invested Capital (ROIC) | 6.54% |
| Return on Capital Employed (ROCE) | 6.33% |
| Weighted Average Cost of Capital (WACC) | 9.17% |
| Revenue Per Employee | $215,511 |
| Profits Per Employee | $8,365 |
| Employee Count | 4,100 |
| Asset Turnover | 1.08 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, UTI has paid $10.96 million in taxes.
| Income Tax | 10.96M |
| Effective Tax Rate | 24.21% |
Stock Price Statistics
The stock price has decreased by -13.38% in the last 52 weeks. The beta is 1.24, so UTI's price volatility has been higher than the market average.
| Beta (5Y) | 1.24 |
| 52-Week Price Change | -13.38% |
| 50-Day Moving Average | 41.22 |
| 200-Day Moving Average | 34.07 |
| Relative Strength Index (RSI) | 30.90 |
| Average Volume (20 Days) | 1,292,328 |
Short Selling Information
The latest short interest is 4.60 million, so 8.34% of the outstanding shares have been sold short.
| Short Interest | 4.60M |
| Short Previous Month | 4.71M |
| Short % of Shares Out | 8.34% |
| Short % of Float | 8.65% |
| Short Ratio (days to cover) | 4.84 |
Income Statement
In the last 12 months, UTI had revenue of $883.60 million and earned $34.30 million in profits. Earnings per share was $0.61.
| Revenue | 883.60M |
| Gross Profit | 481.09M |
| Operating Income | 44.30M |
| Pretax Income | 45.25M |
| Net Income | 34.30M |
| EBITDA | 107.12M |
| EBIT | 44.26M |
| Earnings Per Share (EPS) | $0.61 |
Balance Sheet
The company has $170.12 million in cash and $359.47 million in debt, with a net cash position of -$189.35 million or -$3.44 per share.
| Cash & Cash Equivalents | 170.12M |
| Total Debt | 359.47M |
| Net Cash | -189.35M |
| Net Cash Per Share | -$3.44 |
| Equity (Book Value) | 344.31M |
| Book Value Per Share | 6.25 |
| Working Capital | 59.79M |
Cash Flow
In the last 12 months, operating cash flow was $74.51 million and capital expenditures -$97.38 million, giving a free cash flow of -$22.87 million.
| Operating Cash Flow | 74.51M |
| Capital Expenditures | -97.38M |
| Depreciation & Amortization | 36.87M |
| Net Borrowing | 86.18M |
| Free Cash Flow | -22.87M |
| FCF Per Share | -$0.42 |
Margins
Gross margin is 54.45%, with operating and profit margins of 5.01% and 3.88%.
| Gross Margin | 54.45% |
| Operating Margin | 5.01% |
| Pretax Margin | 5.12% |
| Profit Margin | 3.88% |
| EBITDA Margin | 12.12% |
| EBIT Margin | 5.01% |
| FCF Margin | n/a |
Dividends & Yields
UTI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.30% |
| Shareholder Yield | -0.30% |
| Earnings Yield | 2.15% |
| FCF Yield | -1.43% |
Analyst Forecast
The average price target for UTI is $41.83, which is 44.49% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $41.83 |
| Price Target Difference | 44.49% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 9.40% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
UTI has an Altman Z-Score of 3.3 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.3 |
| Piotroski F-Score | 5 |